Dermatology - European Medical Journal

Continue

Dermatology

Filter
8 Mins
23 Nov 2023

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
2 Mins
23 Nov 2023

Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
10 Mins
23 Nov 2023

A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study

Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…
13 Mins
17 Nov 2023

Platelet-Rich Plasma Applications, The Past 5 Years

This review article aims to provide an overview of platelet-rich plasma’s applications and evidence over the past 5 years in randomised…
9 Mins
26 Oct 2023

Editor's Pick: Diagnostic Evaluation of Hair Loss: A Narrative Review

This review provides a systematic approach for dermatologists to use in order to accurately diagnose hair loss disorders…
10 Mins
12 Oct 2023

Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology

During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients…
5 Mins
5 Oct 2023

Mycosis Fungoides Palmaris et Plantaris Progressing to Complete Early-Stage Disease Improved with Phototherapy

Mycosis fungoides is the most common form of cutaneous T cell lymphoma. In this article, the authors describe a case of a 53-year-old…
8 Mins
5 Sep 2023

Editor’s Pick: Assessing the Relationship Between Vitiligo and Cardiovascular Disease Risk Factors

Vitiligo is an autoimmune disorder characterised by the loss of melanocytes, resulting in white, depigmented cutaneous macules…
We’ve noticed you’re accessing
from North/South America.